Series - Policy
Policy
BIO advocates on behalf of the industry to public policy makers and influencers in United States and around the world, with these recent webinars representing a sample of BIO’s efforts to inform regulatory and legislative decision making.
Global Out-Licensing Considerations for Manufacturers
June 2, 2026
Speakers: Joe Franklin, Amanda Austin , Grant Castle , Winsome Cheung , Kristie Gurley, Crystal Kuntz, Sibel Yilmaz
The biopharmaceutical ecosystem is facing heightened uncertainty, driven by funding constraints, regulatory shifts, and policy reforms—including pricing pressures and the potential expansion of international reference pricing. These dynamics are reshaping dealmaking and raising…
Upcoming

Donna L. LaVoie, Assad Aslam, Bernard V. Fallon, Shiv Krishnan, PhD, Nicola La Monica, PhD, Raphaël G. Ognar, MSc, MBA, Mackensie Vernetti, Brian Wiley
December 8, 2025
Ilyssa Levins-Pimienta, Robert Dean, Howard Dorfman
November 20, 2025
Mackensie Vernetti
October 30, 2025
Jeff Vallerga, Joe Dragavon, Ric Kunnert, Rob Salmon
October 16, 2025
Jeff Vallerga, Matt Curry, Sarah Glazier, Alina Mencias, Dave Tucker
September 11, 2025
Jeff Vallerga, Jose Arellano, Max Conaboy, Gaby Levey, Natalie Marquess
September 9, 2025
Jeff Vallerga, Brandon Clough, Carrie Kleinle, Ric Kunnert, Rob Salmon
September 8, 2025

















